MERS: Protecting Employee Health and Supply Chains
Register Now
Thursday, May 22, 2014
12:00 PM - 1:00 PM US Eastern
11:00 AM - 12:00 PM US Central
10:00 AM - 11:00 AM US Mountain
9:00 AM - 10:00 AM US Pacific
4:00 PM - 5:00 PM GMT

Expert panelists:

http://online.krm.com/krm/10/images/00279763/michaelosterholm.jpg
Director, Center for Infectious Disease Research and Policy
Distinguished University Teaching Professor, Environmental Health Sciences, School of Public Health
Professor, Technological Leadership Institute College of Science and Engineering
Adjunct Professor, Medical School
University of Minnesota
http://online.krm.com/krm/10/images/00279763/pritish-tosh.jpeg
Infectious Diseases Physician
Mayo Clinic
Fellow, Center for Infectious Disease Research and Policy
University of Minnesota
 

Summary

Cases of Middle East respiratory syndrome (MERS) have now topped 600 globally and are mounting at an increasing rate, with multiple cases now confirmed in the United States. About 30% of symptomatic patients identified worldwide have died.
 
On May 14 the World Health Organization (WHO) indicated that the seriousness of the situation has increased in terms of public health impact, but it stopped short of declaring MERS a Public Health Emergency of International Concern (PHEIC). The WHO Emergency Committee will reconvene as circumstances require, but no later than next month.
 
Register now to join one of the world's most sought-after experts on infectious disease threats, Michael Osterholm, PhD, MPH, and Mayo Clinic infectious diseases physician Pritish K. Tosh, MD, for this timely interactive webinar to learn what you need to know now and what you should be monitoring moving forward. Both experts recently returned from the Middle East after serving as senior consultants to government officials on the outbreak.
 
Now is your opportunity to get up-to-speed on this emerging infectious disease threat before the situation potentially escalates further. Register now to join live presentations from the experts for answers to the following questions:
 
  • How much do we really know about MERS and its risk to regional and global public health?
  • What are the chances that MERS will continue to spread and what does that mean for companies and organizations around the world?
  • What does a potential PHEIC declaration mean for your organization?
  • What types of government interventions could affect your operations?
  • What does the current situation mean for employees returning to the United States?
  • Should your company issue travel restrictions?
  • How can your organization best quickly assess and address supply chain vulnerabilities?
  • Do we have a MERS vaccine, and what impact could it have?
  • What is the role of the US government? What is the US government doing?
  • And moreā€¦
 
Following the brief presentations, a moderated question-and-answer session will give Web seminar attendees an opportunity to ask questions of the experts.

Unable to Attend?

Cancellation Policy

Event registrants may cancel their registration without penalty anytime prior to the start of the event.

Register Now